NDC 0002-7797 – Ebglyss
Lebrikizumab 250 mg/2mL · Injection, Solution · Subcutaneous
Product NDC0002-7797
Product details
- Brand name
- Ebglyss
- Generic name
- lebrikizumab-lbkz
- Labeler
- Eli Lilly and Company
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761306
- Marketed since
- September 13, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-13 Antagonist
Active ingredients
- Lebrikizumab 250 mg/2mL
Package NDC codes (2)
| Package NDC | Description | Since |
|---|---|---|
| 0002-7797-11 | 1 SYRINGE in 1 CARTON (0002-7797-11) / 2 mL in 1 SYRINGE (0002-7797-01) | Sep 13, 2024 |
| 0002-7797-61 sample | 1 SYRINGE in 1 CARTON (0002-7797-61) / 2 mL in 1 SYRINGE | Sep 13, 2024 |
Other Ebglyss products
- 0002-7772 Lebrikizumab 250 mg/2mL · Injection, Solution · Eli Lilly and Company